AveXis (AVXS) Was a Buyout Target Before It's IPO and Had Three Other Companies Interested Before Mega Novartis Deal

Go back to AveXis (AVXS) Was a Buyout Target Before It's IPO and Had Three Other Companies Interested Before Mega Novartis Deal

Biogen (BIIB) Reports $1B Payment to Ionis Pharma (IONS) for Expanded Collaboration on Neurological Diseases Drug Development

April 20, 2018 6:37 AM EDT

(Updated - April 20, 2018 6:54 AM EDT)

Biogen (NASDAQ: BIIB) and Ionis Pharmaceuticals (NASDAQ: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogens expertise in neuroscience research and... More